OVERVIEW

Multidisciplinary Management of Prostate Cancer is organized by European Society for Radiotherapy and Oncology (ESTRO) and will be held from Oct 26 - 30, 2025 at Crowne Plaza Verona - Fiera, an IHG Hotel, Verona, Veneto, Italy.

Aim:
This 4-day teaching course aims at focusing on the management of localised, locally advanced and metastatic prostate cancer. It emphasises the importance of a multidisciplinary approach and of teamwork, where full information exchange is vital to provide the best up-to-date scientific evidence on which the management of the disease will be based. This will be illustrated during state-of-the-art lectures presented by experts in the field, covering important issues such as biology, imaging, pathology, therapy and future developments. Interactive case studies and journal clubs will be integrated on a daily basis and there will be ample time for open discussions amongst participants and experts. A special session on target delineation for radiotherapists will also be organised during the course.

Learningoutcomes:

To provide an in-depth overview of the epidemiology, pathology, imaging and treatment options for low, intermediate and high risk prostate cancer
To discuss patient selection/indications and contra-indications for the various treatment options
To provide a critical overview of the surgical and radiotherapy techniques available for the management of prostate cancer
To discuss the new drugs currently available for the management of the advanced and metastatic stages of the disease
To debate on the most recent developments relevant to prostate cancer management.

Course content:

Normal prostate: anatomy embryology, histology
Prostate cancer: epidemiology and prevention, clinical diagnosis, imaging modalities pathology, staging
Prostate cancer management according to risk groups: active surveillance, surgery, radiotherapy
External beam radiotherapy: on-line control, target delineation
Toxicity of radiotherapy: acute and late morbidity erectile dysfunction
Role of surgery and its morbidity
Alternative treatments
Adjuvant and salvage radiotherapy after radical surgery
Rising PSA after surgery and after radiotherapy
Imaging for recurrent detection
Node positive prostate cancer
Hormone sensitive metastatic prostate cancer
Castration resistant prostate cancer
Palliative radiotherapy and surgery
Non systemic treatment in the metastatic setting.
Case discussions.